Published in Thorax on March 01, 1996
Sarcoidosis. Am Rev Respir Dis (1974) 2.99
British Thoracic Society Sarcoidosis study: effects of long term corticosteroid treatment. Thorax (1996) 2.58
Pulmonary sarcoidosis: a prospective evaluation of glucocorticoid therapy. Ann Intern Med (1970) 1.33
Diffuse pulmonary sarcoidosis: diffusing capacity during exercise and other lung function studies in relation to ACTH therapy. Bull Johns Hopkins Hosp (1952) 1.30
A controlled trial of prednisone treatment of sarcoidosis. Am Rev Respir Dis (1973) 1.17
Corticosteroid therapy of pulmonary sarcoidosis. A prospective evaluation of alternate day and daily dosage in stage II disease. Scand J Respir Dis (1979) 1.17
The present status of treatment of pulmonary sarcoidosis: a house divided. Chest (1977) 1.10
Cortisone therapy in sarcoidosis; effect in a case with virtual blindness. J Am Med Assoc (1951) 1.05
Extended experience in the long-term corticosteroid treatment of pulmonary sarcoidosis. Ann N Y Acad Sci (1976) 1.04
Pulmonary sarcoidosis. Long-term follow-up of the effects of steroid therapy. Chest (1982) 1.04
Effects of cortisone in sarcoidosis; a study of thirteen patients. Am J Med (1952) 1.01
Corticosteroid therapy in sarcoidosis. A five-year, controlled follow-up study. N Y State J Med (1987) 1.00
Evidence that steroids alter the natural history of previously untreated progressive pulmonary sarcoidosis. Sarcoidosis (1986) 0.82
Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N Engl J Med (1994) 4.76
Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. N Engl J Med (1991) 4.09
ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis (1999) 3.69
The mode of presentation of sarcoidosis in Finland and Hokkaido, Japan. A comparative analysis of 571 Finnish and 686 Japanese patients. Sarcoidosis Vasc Diffuse Lung Dis (1996) 1.47
Sarcoidosis in identical twins. Observations on the course of treated and untreated identical diseases. Am Rev Respir Dis (1973) 1.44
Elevated angiotensin I-converting enzyme in histiocytic medullary reticulosis. N Engl J Med (1983) 1.29
The frequency of sarcoidosis in Finland and Hokkaido, Japan. A comparative epidemiological study. Sarcoidosis (1995) 1.27
Corticosteroid therapy of pulmonary sarcoidosis. A prospective evaluation of alternate day and daily dosage in stage II disease. Scand J Respir Dis (1979) 1.17
Angiotensin-converting enzyme and lysozyme in silicosis and asbestosis. Scand J Respir Dis (1978) 1.16
Safety of formoterol Turbuhaler at cumulative dose of 90 microg in patients with acute bronchial obstruction. Eur Respir J (2001) 1.06
Thrombocytosis in rheumatoid arthritis. Scand J Rheumatol (1972) 1.05
Thrombocytosis. Acta Med Scand (1973) 1.04
Skin test sensitivity and antigen-induced lymphocyte transformation in uraemia. Clin Exp Immunol (1973) 1.04
Pulmonary sarcoidosis in the Nordic countries 1950-1982. Epidemiology and clinical picture. Sarcoidosis (1990) 1.03
Safety of formoterol by Turbuhaler as reliever medication compared with terbutaline in moderate asthma. Eur Respir J (2002) 1.02
Formoterol (OXIS) Turbuhaler as a rescue therapy compared with salbutamol pMDI plus spacer in patients with acute severe asthma. Respir Med (2003) 1.02
Advances in asthma and COPD treatment: combination therapy with inhaled corticosteroids and long-acting beta 2-agonists. Curr Pharm Des (2006) 0.98
Relationship between lung tissue and blood plasma concentrations of inhaled budesonide. Biopharm Drug Dispos (1993) 0.98
Circulating immune complexes in sarcoidosis. J Clin Lab Immunol (1980) 0.96
True adherence with the Turbuhaler in young children with asthma. Arch Dis Child (2010) 0.95
The angiotensin-converting enzyme DD gene is associated with poor prognosis in Finnish sarcoidosis patients. Eur Respir J (1999) 0.94
Tolerability to high doses of formoterol and terbutaline via Turbuhaler for 3 days in stable asthmatic patients. Eur Respir J (1998) 0.94
Sarcoidosis and myeloma of lambda-type IgG. Acta Med Scand (1974) 0.92
Sarcoidosis with thyroid involvement, polymyalgia rheumatica and breast carcinoma. A case report. Scand J Rheumatol (1976) 0.92
Serum lysozyme in sarcoidosis. Evaluation of its usefulness in determination of disease activity. Scand J Respir Dis (1977) 0.92
Prognostic significance of lymphopenia in sarcoidosis. Acta Med Scand (1979) 0.91
The prognosis of pulmonary sarcoidosis in Finland and Hokkaido, Japan. A comparative five-year study of biopsy-proven cases. Sarcoidosis Vasc Diffuse Lung Dis (2000) 0.90
Treatment with inhaled steroids in patients with symptoms suggestive of asthma but with normal lung function. Eur Respir J (2008) 0.89
Kveim reaction in Crohn's disease. Lancet (1971) 0.88
Family studies in dermatitis herpetiformis. Ann Clin Res (1976) 0.88
Thrombocythaemia and multiple myeloma. A report on two cases. Acta Med Scand (1977) 0.86
Lupus-like syndrome associated with pulmonary reaction to nitrofurantoin. Report of three cases. Acta Med Scand (1975) 0.86
Pulmonary reaction to nitrofurantoin. Acta Med Scand (1969) 0.85
A double-blind, placebo-controlled dose-response study with budesonide Turbuhaler in Japanese asthma patients. Japanese Pulmicort Turbuhaler study group. Respirology (2000) 0.85
Familial sarcoidosis in Finland and Hokkaido, Japan--a comparative study. Respir Med (1999) 0.85
Immunoglobulins in pernicious anaemia. Including a report on a patient with pernicious anaemia, IgA deficiency and an M component of kappa-type IgG. Acta Med Scand (1973) 0.85
Pulmonary sarcoidosis in the Nordic countries 1950-1982. II. Course and prognosis. Sarcoidosis (1990) 0.85
Thrombocytes in fibrinogen-induced arthritis in rabbits. Scand J Rheumatol (1973) 0.84
Effects of inhaled corticosteroids on metalloproteinase-8 and tissue inhibitor of metalloproteinase-1 in the airways of asthmatic children. Int Arch Allergy Immunol (2009) 0.84
Formoterol Turbuhaler as reliever medication in patients with acute asthma. Eur Respir J (2006) 0.84
Formoterol as needed with or without budesonide in patients with intermittent asthma and raised NO levels in exhaled air: A SOMA study. Eur Respir J (2006) 0.83
Sarcoidosis of the spleen. Acta Med Scand (1976) 0.83
Clinical relevance is associated with allergen-specific wheal size in skin prick testing. Clin Exp Allergy (2014) 0.83
Beta 2-agonists administered by a dry powder inhaler can be used in acute asthma. Respir Med (1998) 0.83
Angiotensin converting enzyme. III. Changes in serum level as an indicator of disease activity in untreated sarcoidosis. Scand J Respir Dis (1979) 0.82
Activity of serum adenosine deaminase in sarcoidosis. Clin Chem (1985) 0.81
Exudative pleurisy and sarcoidosis. Br J Dis Chest (1966) 0.81
Fine-needle aspiration biopsy of the spleen in diagnosis of sarcoidosis. Ann N Y Acad Sci (1976) 0.81
Asthma and COPD: differences and similarities. With special reference to the usefulness of budesonide/formoterol in a single inhaler (Symbicort) in both diseases. Int J Clin Pract (2005) 0.79
Usefulness of fine-needle aspiration biopsy of spleen in diagnosis of sarcoidosis. Chest (1983) 0.79
Comparing asthma treatment in elderly versus younger patients. Respir Med (2011) 0.79
Inhaled budesonide influences cellular and biochemical abnormalities in pulmonary sarcoidosis. Sarcoidosis (1988) 0.78
Angiotensin-converting enzyme. II. Serum activity in early and newly diagnosed sarcoidosis. Scand J Respir Dis (1979) 0.78
Angiotensin converting enzyme. V. Serum levels as monitors of disease activity in corticosteroid-treated sarcoidosis. Eur J Respir Dis (1980) 0.77
Infectious mononucleosis with thrombocytopenic purpura. Acta Med Scand (1972) 0.77
Sarcoidosis in the Nordic countries 1950-1987. Sarcoidosis (1992) 0.76
Comparison of two twice-daily doses of budesonide/formoterol maintenance and reliever therapy. Eur Respir J (2010) 0.75
Cellular immunity during follow-up of patients with sarcoidosis of varying duration. Clin Exp Immunol (1982) 0.75
Inhaled corticosteroids and pulmonary sarcoidosis. Eur Respir J (1996) 0.75
The EDICT study. Respir Med (2003) 0.75
Malignant histiocytosis. A clinical and morphological study of four cases. Ann Clin Res (1978) 0.75
Letter: Elevated muramidase levels in histiocytic medullary reticulosis. N Engl J Med (1976) 0.75
Angiotensin-converting enzyme, lysozyme, beta-2-microglobulin and adenosine deaminase in sarcoidosis. Arch Monaldi (1986) 0.75
Relation between clinical stage of sarcoidosis and serum values of angiotensin converting enzyme and beta2-microglobulin. Sarcoidosis (1987) 0.75
Myeloid metaplasia in disseminated vascular disease. Acta Med Scand (1974) 0.75
The effect of isoniazid in one daily dose. Acta Tuberc Pneumol Scand (1965) 0.75
Angiotensin converting enzyme. IV. Changes in serum activity and in lysozyme concentrations as indicators of the course of untreated sarcoidosis. Scand J Respir Dis (1979) 0.75
Drug sensitivity in pulmonary tuberculosis. Incidence of primary and acquired drug-resistance in 1960-1963. Acta Tuberc Pneumol Scand (1965) 0.75
Sarcoidosis of the nose. Including a report on a patient with large sarcoid polypi of the nasal mucosa. Scand J Respir Dis (1977) 0.75
Splenic granulomas in Farmer's lund disease. An extrapulmonary manifestation of extrinsic allergic alveolitis. Acta Med Scand (1982) 0.75
Immunological deficiency in myelofibrosis. Scand J Haematol (1973) 0.75
Blood monocytes and serum and bone marrow lysozyme in sarcoidosis. Acta Med Scand (1981) 0.75
The prognosis of early pulmonary sarcoidosis. Scand J Respir Dis (1966) 0.75
[Sarcoidosis]. Duodecim (1971) 0.75
Polymyalgia rheumatica and chronic lymphatic leukaemia. Scand J Rheumatol (1977) 0.75
[Lactic acidosis and phenformin. A case of successful treatment with hemodialysis]. Nord Med (1968) 0.75
The frequency, clinical picture and prognosis of pulmonary sarcoidosis in Finland. Acta Med Scand Suppl (1969) 0.75
Fine-needle aspiration biopsy of spleen in diagnosis of sarcoidosis. Z Erkr Atmungsorgane (1977) 0.75
Haematologic findings in patients with renal carcinoma. Scand J Urol Nephrol (1981) 0.75
Thrombocytosis in experimental amyloidosis in rabbits. Scand J Rheumatol (1973) 0.75
[Serum angiotensin converting enzyme (ACE) activity in sarcoidosis]. Duodecim (1978) 0.75
[Sarcoidosis]. Lakartidningen (1980) 0.75
The Finnish leukaemia group: levamisole in maintenance therapy of acute myeloid leukemia in adults. Recent Results Cancer Res (1982) 0.75
Pharmacokinetics-art for art's sake, registration requirement or a clinical need? Eur J Respir Dis Suppl (1984) 0.75
Mixed connective tissue syndromes. Scand J Rheumatol Suppl (1975) 0.75
Reversible renal failure and G.-6-P.D. deficiency. Lancet (1972) 0.75
Myocardial sarcoidosis. Scand J Respir Dis (1972) 0.75
Glucose-6-phosphate dehydrogenase deficiency and myelofibrosis. Scand J Haematol (1973) 0.75
Platelet values in amyloidosis. Scand J Rheumatol (1973) 0.75
[Diagnosis of sarcoidosis]. Duodecim (1978) 0.75
[Chronic diarrhea in domestic giardiasis]. Nord Med (1971) 0.75
The diagnosis of sarcoidosis. Eur J Respir Dis (1981) 0.75
[Clinico-pathological conference XXX. Lung changes and eosinophilia with tuberculosis and mitral valve disease]. Duodecim (1975) 0.75
Sarcoidosis in Finland. Acta Med Scand Suppl (1964) 0.75
[Pulmonary mycosis]. Nord Med (1968) 0.75
[Megaloblastic anemia caused by L-asparaginase-induced vitamin B 12 -deficiency]. Nord Med (1971) 0.75
[Sarcoidosis and Crohn's disease--etiological speculations]. Nord Med (1971) 0.75
Immunohistochemical demonstration of lysozyme in the lymph nodes and Kveim reaction papules in sarcoidosis. Acta Pathol Microbiol Scand A (1977) 0.75
[Tuberculosis drugs and their side effects]. Sairaanhoitaja (1966) 0.75